ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 23.56 Delayed Data As of Sep 22 |  +0.16 / +0.68%Today’s Change | 13.73 Today|||52-Week Range 33.99 | +47.99% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Assets | Cash | 63.9M | 134.8M | 97.6M | 74.4M | |
| Short Term Investment Cash | -10.3M | 72.6M | -37.2M | -23.1M | ||
| Cash & Short Term Investments | 214.1M | 473.5M | 414.3M | 381.9M | ||
| Receivables | Receivables | 20.7M | 27.8M | 33.8M | 32.7M | |
| Inventories | Inventories | 4.3M | 4.1M | 4.6M | 3.8M | |
| Current Assets | Prepaid Expenses | 15.0M | 20.7M | 23.7M | 18.5M | |
| Current Assets | 254.1M | 526.1M | 476.4M | 436.9M | ||
| Total Assets | Property, Plant and Equipment - Gross | -- | 7.5M | -- | -- | |
| Depreciation | -- | -4.2M | -- | -- | ||
| Intangible Assets | 4.4M | 4.1M | 3.7M | 3.3M | ||
| Other Assets | 5.9M | 6.0M | 5.3M | 4.9M | ||
| Total Assets | 266.5M | 540.2M | 501.1M | 460.9M | ||
| Liabilities | Accounts Payable | 3.0M | 3.2M | 3.3M | 4.7M | |
| Short Term Debt | 0.00 | 0.00 | 4.5M | 4.4M | ||
| Accrued Expenses | 24.4M | 33.5M | 34.2M | 31.9M | ||
| Other Current Liabilities | 24.4M | 33.5M | 34.2M | 31.9M | ||
| Other Liabilities | 41.8M | 59.6M | 75.0M | 63.8M | ||
| Total Liabilities | Long Term Debt | -- | 0.00 | 6.8M | 6.7M | |
| Other Liabilities | 1.2M | 1.6M | 1.0M | 1.4M | ||
| Total Liabilities | 43.0M | 61.1M | 82.7M | 72.0M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 223.4M | 479.1M | 418.4M | 388.9M | ||
| Total Shareholder Equity | 223.4M | 479.1M | 418.4M | 388.9M | ||
| Share Information | Common Shares Outstanding | 125.0M | 143.9M | 144.1M | 144.5M | |
| Addtl. Info. | No data currently available for this section. | |||||
